Trinity Biotech (TRIB) Reports In-Line Q3 EPS

Trinity Biotech (NASDAQ: TRIB) reported Q3 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $26.1 million versus the consensus estimate of $26.5 million.

For earnings history and earnings-related data on Trinity Biotech (TRIB) click here.

You May Also Be Interested In

• Growth isn't weak enough to truly undercut inflation pressures - BMO
• American Express (AXP) down despite beating Q1 estimates on top and bottom lines
• Acme United (ACU) Misses Q1 EPS by 20c